UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 5.439

Sortiert nach

Treatment of prednisolone‐induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study

Diabetes, obesity & metabolism, 2017-04, Vol.19 (4), p.571-578

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia‐prone people with Type 1 diabetes

Diabetic medicine, 2017-05, Vol.34 (5), p.625-631

2017

Link zum Volltext

Verfügbarkeit prüfen

Drug treatments for managing cystic fibrosis-related diabetes

Cochrane database of systematic reviews, 2020-10, Vol.10 (10), p.CD004730-CD004730

2020

Link zum Volltext

Verfügbarkeit prüfen

Choice of basal insulin therapy is associated with weight and height development in type 1 diabetes: A multicenter analysis from the German/Austrian DPV registry in 10 338 children and adolescents

Journal of diabetes, 2021-11, Vol.13 (11), p.930-939

2021

Link zum Volltext

Verfügbarkeit prüfen

Insulin and oral agents for managing cystic fibrosis-related diabetes

Cochrane database of systematic reviews, 2016-04, Vol.4, p.CD004730-CD004730

2016

Link zum Volltext

Verfügbarkeit prüfen

Environmental effects of ambient temperature and relative humidity on insulin pharmacodynamics in adults with type 1 diabetes mellitus

Diabetes, obesity & metabolism, 2019-03, Vol.21 (3), p.569-574

2019

Link zum Volltext

Verfügbarkeit prüfen

Optimal prandial timing of bolus insulin in diabetes management: a review

Diabetic medicine, 2018-03, Vol.35 (3), p.306-316

2018

Link zum Volltext

Verfügbarkeit prüfen

Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial

Journal of diabetes, 2016-05, Vol.8 (3), p.405-413

2016

Link zum Volltext

Verfügbarkeit prüfen

Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes

Diabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.419-426

2018

Link zum Volltext

Verfügbarkeit prüfen

Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)

Diabetes, obesity & metabolism, 2015-12, Vol.17 (12), p.1133-1141

2015

Link zum Volltext

Verfügbarkeit prüfen

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension

Diabetes, obesity & metabolism, 2015-09, Vol.17 (9), p.835-842

2015

Link zum Volltext

Verfügbarkeit prüfen

Decrease in clinical hypoglycemia in young children with type 1 diabetes treated with free-mixed aspart and detemir insulin: an open labeled randomized trial

Pediatric diabetes, 2015-08, Vol.16 (5), p.345-353

2015

Link zum Volltext

Verfügbarkeit prüfen

Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment

CNS neuroscience & therapeutics, 2018-09, Vol.24 (9), p.763-774

2018

Link zum Volltext

Verfügbarkeit prüfen

Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Diabetic medicine, 2015-05, Vol.32 (5), p.585-594

2015

Link zum Volltext

Verfügbarkeit prüfen

Enterically delivered insulin tregopil exhibits rapid absorption characteristics and a pharmacodynamic effect similar to human insulin in conscious dogs

Diabetes, obesity & metabolism, 2019-01, Vol.21 (1), p.160-169

2019

Link zum Volltext

Verfügbarkeit prüfen

A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive heart failure exacerbation

Diabetes/metabolism research and reviews, 2015-01, Vol.31 (1), p.93-101

2015

Link zum Volltext

Verfügbarkeit prüfen

Glucose‐Responsive Insulin and Delivery Systems: Innovation and Translation

Advanced materials (Weinheim), 2020-04, Vol.32 (13), p.e1902004-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2005-01, Vol.7 (1), p.56-64

2005

Link zum Volltext

Verfügbarkeit prüfen

Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes

Diabetic medicine, 2016-04, Vol.33 (4), p.497-505

2016

Link zum Volltext

Verfügbarkeit prüfen

Peripherally delivered hepatopreferential insulin analog insulin‐406 mimics the hypoglycaemia‐sparing effect of portal vein human insulin infusion in dogs

Diabetes, obesity & metabolism, 2019-10, Vol.21 (10), p.2294-2304

2019

Link zum Volltext

Verfügbarkeit prüfen

Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine

Diabetes, obesity & metabolism, 2010-09, Vol.12 (9), p.772-779

2010

Link zum Volltext

Verfügbarkeit prüfen

Intention-to-treat analysis with treatment discontinuation and missing data in clinical trials

Statistics in medicine, 2015-07, Vol.34 (16), p.2381-2390

2015

Link zum Volltext

Verfügbarkeit prüfen

Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial

Diabetes, obesity & metabolism, 2017-04, Vol.19 (4), p.579-589

2017

Link zum Volltext

Verfügbarkeit prüfen

Diabetes and Cancer: A Consensus Report

CA: a cancer journal for clinicians, 2010-07, Vol.60 (4), p.207-221

2010

Link zum Volltext

Verfügbarkeit prüfen

Oral Insulin Delivery Platforms: Strategies To Address the Biological Barriers

Angewandte Chemie (International ed.), 2020-11, Vol.59 (45), p.19787-19795

International ed. in English, 2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 5.439

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library - AutoHoldings Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.686)
Mit Volltextzugriff
(4.666)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(4.817)
Life Sciences & Biomedicine
(4.751)
Humans
(4.046)
Male
(3.463)
Female
(2.883)
Insulin - Administration & Dosage
(2.173)
Endocrinology & Metabolism
(2.045)
Adult
(1.738)
Animals
(1.694)
Insulin
(1.675)
Middle Aged
(1.643)
Biological And Medical Sciences
(1.589)
Hypoglycemic Agents - Administration & Dosage
(1.578)
Medical Sciences
(1.396)
Diabetes
(1.301)
Blood Glucose - Metabolism
(1.283)
Insulin - Blood
(1.124)
Diabetes Mellitus, Type 2 - Drug Therapy
(964)
Aged
(951)
Diabetes Mellitus, Type 1 - Drug Therapy
(900)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Treatment of prednisolone‐induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study

Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia‐prone people with Type 1 diabetes

Drug treatments for managing cystic fibrosis-related diabetes

Choice of basal insulin therapy is associated with weight and height development in type 1 diabetes: A multicenter analysis from the German/Austrian DPV registry in 10 338 children and adolescents

Insulin and oral agents for managing cystic fibrosis-related diabetes

Environmental effects of ambient temperature and relative humidity on insulin pharmacodynamics in adults with type 1 diabetes mellitus

Optimal prandial timing of bolus insulin in diabetes management: a review

Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial

Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes

Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension

Decrease in clinical hypoglycemia in young children with type 1 diabetes treated with free-mixed aspart and detemir insulin: an open labeled randomized trial

Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment

Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Enterically delivered insulin tregopil exhibits rapid absorption characteristics and a pharmacodynamic effect similar to human insulin in conscious dogs

A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive heart failure exacerbation

Glucose‐Responsive Insulin and Delivery Systems: Innovation and Translation

Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes

Peripherally delivered hepatopreferential insulin analog insulin‐406 mimics the hypoglycaemia‐sparing effect of portal vein human insulin infusion in dogs

Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine

Intention-to-treat analysis with treatment discontinuation and missing data in clinical trials

Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial

Diabetes and Cancer: A Consensus Report

Oral Insulin Delivery Platforms: Strategies To Address the Biological Barriers

Aktive Filter

Suchergebnisse filtern